skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8830

A retrospective database analysis of insulin use patterns in insulin-naïve patients with type 2 diabetes initiating basal insulin or mixtures

Other

(1962) Views  (539) Full article downloads

Authors: Machaon MK Bonafede, Anupama Kalsekar, Manjiri Pawaskar, et al

Published Date June 2010 Volume 2010:4 Pages 147 - 156
DOI: http://dx.doi.org/10.2147/PPA.S10467

Machaon MK Bonafede1, Anupama Kalsekar2, Manjiri Pawaskar2, Kimberly M Ruiz3, Amelito M Torres3, Karen R Kelly2, Suellen M Curkendall3

1Thomson Reuters Inc, Cambridge, Massachusetts, USA; 2Eli Lilly and Company, Indianapolis, Indiana, USA; 3Thomson Reuters Inc, Washington, DC, USA

Objective: To describe insulin persistence among patients with type 2 diabetes initiating insulin therapy with basal insulin or insulin mixtures and determine factors associated with nonpersistence.

Research design and methods: The Thomson Reuters MarketScan® databases were used to retrospectively analyze insulin-naïve patients with type 2 diabetes by initiating insulin therapy. Insulin use was described using a variety of measures. The persistence to insulin was described using both a gap-based measure and the number of claims measure.

Results: Patients in the basal insulin cohort (N = 15,255) primarily used insulin analogs (88.1%) and vial and syringe (97%). Patients in the mixture cohort (N = 2,732) were more likely to initiate on human insulin mixtures (62.5%) and vial and syringe (68.1%). Average time between insulin refills was 80 and 71 days for basal and mixture initiators, respectively. Nearly, 75% of basal insulin initiators and 65% of insulin mixture initiators had a 90-day gap in insulin prescriptions. More than half of all the patients had at least one insulin prescription per quarter. Patients initiating with insulin analogs were more likely to be persistent compared with those initiating with human insulin across both cohorts and measures of persistence (P < 0.001).

Conclusion: Persistence to insulin therapy is poorer than one would anticipate, but appears to be higher in users of insulin analogs and insulin mixtures.

Keywords: insulin persistence, basal insulin, insulin mixtures








Readers of this article also read:

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utility
Exploring patients’ perceptions for insulin therapy in type 2 diabetes: a Brazilian and Canadian qualitative study
Clinicoradiological features of recurrent ischemic stroke: healthcare for poststroke patients
Using systematically observed clinical encounters (SOCEs) to assess medical students’ skills in clinical settings
Insulin therapy in critically ill patients
Primary care for diabetes mellitus: perspective from older patients
Incidence of adverse events with telmisartan compared with ACE inhibitors: evidence from a pooled analysis of clinical trials
Impact of pharmacist interventions on patients' adherence to antidepressants and patient-reported outcomes: a systematic review
The impact of HIV clinical pharmacists on HIV treatment outcomes: a systematic review